Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Moderate hyperphenylalaninemia (mHPA) is a hydroxylase deficiency corresponding to phenylalanine levels, at newborn screening, below 360 μmol/l. The neurological impact of mHPA is usually considered to be very low, but few studies have investigated the neuropsychological profile of mHPA patients.A systematic review of the neuropsychological aspects of mHPA was therefore conducted.The results showed a preservation of cognitive functions (intelligence, memory, visuoperception…). However, several indicators point to executive difficulties in this population. In regard to the important impact of executive functions in daily life, it is essential to conduct other studies in mHPA patients by proposing an integrative approach.

Citation

L Paermentier, A Cano, B Chabrol, A Roy. Neuropsychological Disorders in Moderate Hyperphenylalaninemia: Literature Review. Developmental neuropsychology. 2023 Jan-Feb;48(1):31-45

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 36594744

View Full Text